Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

Raloxifene claimed as treatment for excess bradykinin-related conditions

July 26, 1996

Selective beta3-adrenoceptor agonists in Dainippon's pipeline

July 26, 1996

CL-316243: Claimed as gastrointestinal disorders treatment by Glaxo Wellcome

July 26, 1996

Anti-H. pylori compound from Toyama

July 26, 1996

Thiophene and thiophene derivatives described by Sankyo as ulcer treatment

July 26, 1996

Anti-H. pylori cephem compounds described by Fujisawa

July 26, 1996

Leiras claims oral delivery system for oxybutynin chloride

July 26, 1996

Novo Nordisk claims xanomeline as potential urinary bladder disorder treatment

July 26, 1996

Antithrombotic/antiallergic TxA2 synthase inhibitors from Terumo

July 26, 1996

D-HG: DIC/thrombosis treatment

July 26, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...